Compound K - An immunomodulator of macrophages in inflammation

Life Sci. 2023 Jun 15:323:121700. doi: 10.1016/j.lfs.2023.121700. Epub 2023 Apr 15.

Abstract

Compound K (CK) is a secondary ginsenoside biotransformed from ginseng. This review discusses the function of CK as a potential ligand of the glucocorticoid receptor and a regulator of macrophage inflammatory responses. We provide findings on the ability of CK to inhibit the activation of M1 macrophages and promote the activation and differentiation of M2 macrophages. In addition, the effect of inhibiting the inflammasome response was collected. We summarized the evidences that CK is effective in the treatment of various inflammatory diseases such as rheumatoid arthritis, systemic lupus erythematosus, dermatitis, asthma, chronic obstructive pulmonary disease, sepsis associated encephalopathy, atherosclerosis, inflammatory bowel disease, and diabetes. These findings suggest the potential of CK as a therapeutic agent that can resolve inflammation and restore homeostasis.

Keywords: Compound K; Ginseng; Glucocorticoid; Glucocorticoid receptor; Inflammasome; M1 macrophages; M2 macrophages.

Publication types

  • Review

MeSH terms

  • Adjuvants, Immunologic / pharmacology
  • Ginsenosides* / pharmacology
  • Ginsenosides* / therapeutic use
  • Humans
  • Immunologic Factors / pharmacology
  • Inflammation / drug therapy
  • Macrophages

Substances

  • ginsenoside M1
  • Ginsenosides
  • Immunologic Factors
  • Adjuvants, Immunologic